AI assistant
KROMEK GROUP PLC — Director's Dealing 2016
Jul 20, 2016
7753_dirs_2016-07-20_633d6b12-49be-429d-a6a7-b3c15e9c4de9.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 7272E
Kromek Group PLC
20 July 2016
20 July 2016
Kromek Group plc
("Kromek" or the "Company")
Director/PDMR Shareholding
Kromek (AIM: KMK), a radiation detection technology company focusing on the medical, security and nuclear markets, announces that it has today received notification that Dr. Arnab Basu, Chief Executive Officer of the Company, today exercised options over 800,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares") pursuant to the EMI share option scheme.
Following the purchase, Dr. Basu has an interest in 2,872,000 Ordinary Shares representing 1.89% of the entire current issued share capital of the Company.
Enquiries
| Kromek Group plc | |
| Arnab Basu, CEO Derek Bulmer, CFO |
+44 (0)1740 626 060 |
| Cenkos Securities plc | |
| Bobbie Hilliam (NOMAD) Julian Morse (Sales) |
+44 (0)20 7397 8900 |
| Luther Pendragon Ltd | |
| Harry Chathli, Claire Norbury, Alexis Gore | +44 (0)20 7618 9100 |
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. The information set out below is provided in accordance with the requirements of Article 19(3) of that Regulation.
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Dr Arnab Basu
2
Reason for the notification
a)
Position/status
Chief Executive Officer
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Kromek Group plc
b)
LEI
N/a
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary Shares of 1p each
b)
Nature of the transaction
Exercise of options over Ordinary Shares
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| 1.5p (exercise price) | 800,000 |
d)
Aggregated information
- Aggregated volume
- Price
800,000
1.5p (exercise price)
e)
Date of the transaction
20 July 2016
f)
Place of the transaction
N/a
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHAKKDKCBKKNOB